How DNA evidence creates victims of chance
By Linda Geddes,
The New Scientist
| 08. 18. 2010
CHARLES RICHARD SMITH has learned the hard way that you can prove almost anything with statistics. In 2009 a disputed statistic provided by a DNA analyst landed him with a 25-year jail sentence.
Smith was convicted of a sexual assault on Mary Jackson (not her real name) in Sacramento, California, which took place in January 2006. Jackson was sitting in a parking lot when a stranger jumped into her truck and made her drive to a remote location before forcing her to perform oral sex on him. When police arrested Smith and took a swab of cells from his penis, they found a second person's DNA mixed with his own.
The DNA analyst who testified in Smith's trial said the chances of the DNA coming from someone other than Jackson were 1 in 95,000. But both the prosecution and the analyst's supervisor said the odds were more like 1 in 47. A later review of the evidence suggested that the chances of the second person's DNA coming from someone other than Jackson were closer to 1 in 13, while a...
Related Articles
By Jan Ransom and Ashley Southall, The New York Times | 03.31.2019
When Karina Vetrano was found beaten and strangled in a Queens park nearly three years ago, the New York Police Department carried out one of the most intense and extensive manhunts in the agency’s recent history.
But defense lawyers for...
By Clive Thompson, Smithsonian | 04.01.2019
At 9:00 a.m. last December 14, a man in Orange County, California, discovered he’d been robbed. Someone had swiped his Volkswagen Golf, his MacBook Air and some headphones. The police arrived and did something that is increasingly a part of...
At the end of 2018, Bill Gates, the multi-billionaire co-founder of Microsoft, used his personal blog to ruminate on “what’s going well and what isn’t with innovation in some areas where I work.”
The specific topics he addressed were Alzheimer’s disease, polio, energy, the next epidemic (probably flu), and gene editing – specifically, human germline gene editing. (Somatic gene editing, he notes, is less controversial.) Gates opens by referring to He Jiankui:
I agree with those who say this scientist...
Following a Biopolitical Times tradition, we present some of our favorite blog posts of the past year, in chronological order. As ever, a wide range of people contributed; most wrote more than one post – apologies to anyone whose favorite of their own work was not selected. There are certainly many more worth your time, which can be found at the Biopolitical Times archive; scroll down and “VIEW MORE” as needed.
Thanks to all the contributors – guests, staff...
